MDXH
MDXH
NASDAQ · Biotechnology

Mdxhealth

$0.15
+0.00 (+3.40%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 3 25%
Sell 0 0%
Price Target
Analyst Price Target +12,812.8% upside
Low Target $16.83
Average Target $19.24
High Target $29.48
Current Price $0.15
Current
$0.15
Target
$19.24
$16.83 $19.24 avg $29.48
Scenario Analysis
Bear Case
$16.83
11,195.3%
Low target
Base Case
$19.24
+12,812.8%
Avg target
Bull Case
$29.48
+19,685.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.46
-96.7% from high
52-Week Low
$0.14
+8.8% from low
Target vs 52W High
$19.24
+331.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +114.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -17.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -30.6%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.5%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -31.6%